IFNB1 and infection: Given that 24 h treatment with IFN-β and IFN-λ enhanced inhibition of EBOVΔVP30 infection over 6 h treatment (Figure 3), DEGs uniquely expressed between 6 h and 24 h of treatment may directly or indirectly inhibit EBOV infection.